Hypertension is associated with an increased risk of cognitive decline, which is generally regarded as a consequence of advanced cerebral atherosclerosis. Many hypertensive patients, however, suffer from cognitive decline long before they have any signs of cerebrovascular disease. Therefore, this study examines direct effects of blood pressure on neurotransmitter status in the hippocampus, a vulnerable cerebral structure relevant for memory consolidation. Absolute glutamate concentration and N-acetylaspartate (NAA) concentration as an alternative marker of neuronal integrity were determined in the hippocampus and the cerebral cortex (anterior cingulate cortex; ACC) by 3-T proton magnetic resonance spectroscopy in 16 probands without any history of cerebrovascular disease. Memory function was tested by the auditory verbal learning test (AVLT) and the rivermead behavioural memory test (RBMT). Arterial stiffness was assessed by augmentation index (AI). Mean arterial pressure showed a significant negative age-adjusted correlation to absolute glutamate concentrations in the hippocampus (R ¼ À0.655, P ¼ 0.011), but not in the ACC. There was no significant correlation of mean arterial pressure and NAA in either hippocampus or ACC. AI did not affect hippocampal glutamate. Moreover, there was a significant negative correlation between mean arterial pressure and AVLT (r ¼ À0.558, P ¼ 0.025) and RBMT score (r ¼ À0.555, P ¼ 0.026). There is an inverse relation between blood pressure and the concentration of hippocampal glutamate. Glutamate is essential for long-term potentiation, the neurobiological correlate for memory formation in the hippocampus. Thus, hypertension-associated cognitive decline may not only be mediated by structural atherosclerotic wall changes, but also by functional changes in neurotransmission.
Introduction
Hypertension is associated with an increased risk of cognitive decline. Several trials, such as Framingham, EVA and PROGRESS, show an association of midlife hypertension and cognitive dysfunction. [1] [2] [3] Hypertension increases the risk of dementia regardless of type, including Alzheimer's disease. 4, 5 In the HOPE and the SYST-EUR studies, treatment of hypertension led to a reduction of cognitive decline of 41 and 50%, respectively. 6, 7 The most evident association between blood pressure and cognitive dysfunction is the development of vascular dementia. Vascular dementia is the second most common form of dementia after Alzheimer's disease, and it constitutes 10-20% of all cases of dementia. 8, 9 Cognitive deficits associated with vascular disease that do not fulfil the criteria of dementia are called 'vascular cognitive impairment, no dementia' or 'mild cognitive impairment'. After the traditional definition of vascular dementia, two pathological entities may be distinguished: large artery disease with cortical infarctions and small artery disease with either subcortical lacunes or chronic subcortical ischaemia. 10 Our present pathophysiological understanding of both entities is based on the concept of irreversible atherosclerotic wall changes leading to ischaemic degeneration of neuronal tissue. Many hypertensive patients, however, show signs of cognitive decline in the absence of detectable cerebral lesions. Moreover, several studies have shown that hypertension contributes to the development of other forms of dementia including Alzheimer's disease without showing any features of cerebrovascular disease in neuroimaging studies. 11 Thus, the question arises whether only structural irreversible atherosclerotic vascular wall changes are involved in the hypertension-associated cognitive decline or if there are additional blood pressure-dependent functional changes, for example in neurotransmitter status, that may contribute to this phenomenon.
This study examines the impact of blood pressure and arterial function on neurotransmitter status in an essential and vulnerable cerebral structure for mnestic function-the hippocampus-in normotensive or mildly hypertensive probands without any history of cerebrovascular disease. Moreover, memory function has been tested by the auditory verbal learning test (AVLT) and the rivermead behavioural memory test (RBMT), which reflect hippocampusassociated memory function.
We examined glutamatate and N-acetylaspartate (NAA) concentrations in the hippocampus and-as a cortical reference-in the anterior cingulate cortex (ACC). Glutamate is the main excitatory neurotransmitter in the hippocampus and it is a crucial prerequisite for long-term potentiation, the neurobiological correlate for memory formation in the hippocampus. NAA is a marker of neuronal integrity and plasticity.
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Materials and methods
Study population
A total of 16 healthy participants, all of whom were unrelated individuals (8 male, 8 female, mean age 28.9±7.8 years, range 20-47 years) were recruited for this study by newspaper advertisement. The presence of either normotension (systolic blood pressure o120 mm Hg, diastolic blood pressure o80 mm Hg), prehypertension (systolic blood pressure 120-139 mm Hg, diastolic blood pressure 80-89 mm Hg) or hypertension stage 1 (systolic blood pressure 140-159 mm Hg, diastolic blood pressure 90-99 mm Hg) was defined as inclusion criterion. The presence of any other kind of cardiovascular disease, cerebrovascular disease, diabetes mellitus, hyperlipidaemia or intake of any medication was an exclusion criterion for this study. The study was approved by the ethics committee of the Charité University Medicine Berlin. Written informed consent was obtained from all participants.
Magnetic resonance spectroscopy
Magnetic resonance measurements were carried out on a 3-T scanner (MEDSPEC 30/100, Bruker Biospin, Ettlingen, Germany) using a circularly polarized head coil. T 1 -weighted images were acquired using modified driven equilibrium Fourier transform (TE ¼ 3.8 ms, TR ¼ 20.53 ms, 128 contiguous slices of 1.5 mm thickness, 1 mm x-y resolution). Magnetic resonance spectra were acquired from 2 Â 3 Â 2 cm 3 voxels including the left hippocampus, and from 2.5 Â 4 Â 2 cm 3 voxels including the anterior cingulate of the volunteer brains using point resolved spectroscopy. The methodology applied for glutamate quantification (briefly described below) has been shown to yield maximum selectivity for glutamate over glutamine and GABA. 14 Eight subspectra of 16 phase cycled scans each were recorded with T R ¼ 3 s, giving 128 averages, at an echo time of 80 ms to obtain maximum selectivity for the glutamate C4 resonance. Post-processing included eddy current correction using water-unsuppressed spectra (n ¼ 8) and automatic frequency shift correction. Spectral fitting was carried out using a program package based on a time domainfrequency domain fitting procedure, 14, 15 including phantom basis spectra, earlier knowledge and background estimation by regularization. For the glutamate quantification constant frequency, differences for glutamate, glutamine and NAA, and equal linewidths were imposed. Mean uncertainties (corresponding to Cramér-Rao lower bounds with added uncertainties from background modelling) for the fitting of glutamate were as low as 13.1% for the hippocampus voxel and 10.5% for the ACC voxel. The fitted metabolite amplitudes were corrected for different coil loading by the phantom and the individual subject's head using the principle of reciprocity, and for relaxation effects using effective transverse relaxation times of the glutamate C4 resonance as determined earlier: 171 ± 22 ms for the hippocampus and 194 ± 37 ms for the anterior cingulate voxel. 16 To correct the metabolite concentrations for the fraction of cerebrospinal fluid in the voxels studied, segmentation into grey matter, white matter and cerebrospinal fluid of the T 1 -weighted images was performed using spm99. 17 
Mnestic function (AVLT, RBMT)
The AVLT, 18 a measure of verbal learning and memory, consists of 15 words that are read one at a time (one word per second) by the examiner. The volunteer has to recall all the words that he can remember. This procedure is repeated five times. As the main target parameter, the mean number of correctly recalled items in trials 1-5 was computed.
The RBMT was developed to detect daily memory functioning deterioration and shows a good ecological validity. 19 The RBMT was initially designed for a brain-injured population, but has also been shown to be a useful measure of memory function in other populations. 20 The immediate recall of detailed items of a short story was the main target parameter of the test.
Blood pressure measurement and assessment of arterial elasticity by augmentation index Augmentation index (AI), systolic blood pressure, diastolic blood pressure and heart rate were measured by the HEM-9000AI device (Omron Healthcare, Kyoto, Japan) as published earlier. 21 All measurements were conducted in a quiet clinical research laboratory at a constant ambient temperature of 20 to 22 1C between 1400 and 1600 hours. Patients were resting in a supine position for 15 min before the measurement procedure was started. Blood pressure was measured oscillometrically according to American and European guidelines. 22, 23 Mean arterial pressure was calculated as diastolic pressure þ 1/3 Â pulse pressure. The AI is a well-established measure of arterial elasticity. It was assessed by computerized radial artery pulse wave analysis. The HEM-9000AI device makes use of a multi-sensor array technology to detect pulse waves by applanation tonometry. The AI was calculated as the difference between the first and second systolic peak of the pulsewave. As AI depends on heart rate, the device offers a software tool that adjusts AI to a heart rate of 75 per min (AI 75 ). Three measurements were performed and mean values for blood pressure and AI were used for statistical evaluation.
Statistical analyses
Statistical calculations were carried out using PASW Statistics 18. Correlation analyses were performed with Pearson's correlation controlled for age. Multiple comparison effects were corrected by adjustment of significance levels according to Bonferroni (1/n). Multiple linear regression analysis was performed to investigate modulating effects of age, blood pressure and AI on hippocampal glutamate and mnestic function. All tests were performed with a two-tailed type-I error rate of Po0.05. With regard to the multiple linear regression, a sample size of 16 probands yields a power of 82% to detect an R 2 of 0.5 attributed to the three independent variables using an F-test with a significance level of 0.05.
Results
Data on age, blood pressure, AI 75 , neurotransmission (glutamate and NAA) in hippocampus and ACC, and mnestic function (AVLT and RBMT) are presented in Table 1 . No significant differences were observed between males and females. Age correlated significantly with the glutamate concentration in both voxels and with the NAA concentration in the ACC, concentrations decreasing with increasing age. Thus, the correlation analyses between mean arterial pressure and metabolite concentrations were controlled for age. As presented in Table 2 , mean arterial pressure showed a significant negative correlation to the glutamate concentration in the hippocampus, but not in the ACC. This association remained significant after correction according to Bonferroni (0.05/4 ¼ 0.0125). There was no significant correlation of mean arterial pressure and NAA in either hippocampus or ACC. Figure 1 illustrates the association of mean arterial pressure and glutamate in the hippocampus. Memory function was assessed by the AVLT and the RBMT (Figure 2 ). There was a significant negative correlation between mean arterial pressure and both AVLT (mean of five trials; r ¼ À0.558, P ¼ 0.025) and RBMT (r ¼ À0.555, P ¼ 0.026). To investigate further modulating parameters on cognitive function, linear regression was performed. The dependent variable AVLT was significantly affected by mean arterial pressure (T ¼ À2.317; P ¼ 0.039), but not by age (T ¼ 0.349; P ¼ 0.733) or the AI 75 (T ¼ À0.280; P ¼ 0.784). In a second linear regression, the dependent variable RBMT was significantly affected by mean arterial pressure (T ¼ À2.436; P ¼ 0.031), but not by age (T ¼ 0.604; P ¼ 0.557) or the AI 75 (T ¼ À0.077; P ¼ 0.940).
Discussion
Many hypertensive patients suffer from cognitive decline even though they have no signs of cerebrovascular disease in neuroimaging studies. Therefore, this study examined the impact of blood pressure and arterial function on neurotransmitter status in the hippocampus. Our data showed a robust correlation between mean arterial pressure and hippocampal glutamate concentration, which remained significant after correction for both age and multiple comparisons.
There was no significant correlation of blood pressure and NAA in either hippocampus or ACC. NAA is regarded as a typical marker of neuronal integrity and plasticity. 12, 13, 24 A decreased NAA concentration reflects neuronal loss or dysfunction and has been reported in cerebral small and large vessel disease. [25] [26] [27] This study population consisted of rather young and healthy subjects. Consistently, there were no correlations of age or mean arterial pressure with NAA in hippocampus or ACC.
The hippocampus and the medial temporal lobe are essential for the episodic memory system. After preprocessing in the entorhinal cortex and dentate gyrus, the hippocampus allows the memory to be stored so that it can later be recalled. 28 Glutamatergic and cholinergic pathways constitute the main excitatory transmitter systems for neuronal activity and plasticity in the hippocampus. It has been shown that brain ageing causes deficits in hippocampal glutamatergic transmission. 29 Interestingly, we found no association of glutamate and blood pressure in the ACC, indicating that the observed Blood pressure and hippocampal glutamate TH Westhoff et al association of blood pressure and glutamate is not a global cerebral phenomenon.
In which way do hippocampal glutamate concentrations mirror functional properties of the hippocampus? There are both animal and human studies showing that low hippocampal glutamate is associated with disturbed memory function. For example, dysfunction or blockade of the NMDA receptor leads to a deficiency in learning in mice/ rats. 30, 31 Moreover, a toluene-induced reduction of hippocampal glutamate in mice is accompanied by a poor learning performance. 32 Also in human beings, several studies suggest a link between decreased glutamatergic neurotransmission and hippocampal functions. 33 When healthy subjects are treated with NMDA antagonists such as phencyclidine or ketamine, declarative as well as explicit memory functions are impaired. 34, 35 Blood pressure did not only affect hippocampal glutamate status. Memory function as a marker of hippocampal integrity showed a significant correlation to the mean arterial pressure as well. Multiple regression revealed that memory function was independent of age and arterial stiffness in this homogeneous young and healthy study population. It has to be emphasized that the two mnestic tests in this trial reflect only a fragment of global cognitive potency. Therefore, our findings may not be misinterpreted as a generalized statement such as 'the lower the blood pressure, the better the memory function'. The present findings just reflect the association between blood pressure and hippocampal neurotransmitter status and hippocampusdependent memory performance.
A trial in elderly hypertensives ('Kungsholm Project') provided evidence for a positive association between arterial stiffness and cognitive disorders. 36 This study was intended to describe blood pressure-dependent functional changes in neurotransmission before there are any signs of advanced atherosclerosis. Indeed, the mean AI 75 of 57.4% reflects normal age-adjusted arterial elasticity in the study population. Besides pulse wave velocity, the estimation of AI is the gold standard of non-invasive assessment of arterial stiffness. AI 75 did not correlate with either glutamate or NAA concentrations in the hippocampus or ACC. Furthermore, there was no association between stiffness and memory function in both mnestic tests. Hence, the reported association of blood pressure and both hippocampal glutamate and mnestic function does not result from advanced atherosclerotic wall changes as seen in manifest cerebrovascular disease.
The cognitive decline associated with hypertension has been largely attributed to advanced cerebral atherosclerosis, although many patients present no signs of cerebrovascular disease. This study shows that blood pressure affects cognitive function on the level of neurotransmission as well. There is an inverse relationship between mean arterial pressure and hippocampal glutamate concentration that is independent of arterial stiffness. As summarized in Table 3 , these findings may contribute to our understanding of the aetiology of hypertensioninduced cognitive decline. These results should be confirmed in a larger sample size including subjects with severe hypertension.
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